LBX Pharmacy Chain (SHA:603883) proposed to subscribe 50 million yuan to a private equity fund as a limited partner, according to a Shanghai bourse filing on Wednesday.
The fund, Ningbo Zhixing Yueheng Venture Capital Partnership (Limited Partnership), will invest in projects related to artificial intelligence, hardware manufacturing, and applications in fields such as biomedicine, technology and the consumer market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.